Director, Business Development

About   Iovance Biotherapeutics, Inc.   Iovance Biotherapeutics , Inc.  is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time treatment for previously treated advanced melanoma, now approved in three global markets and available at more than 95 authorized treatment centers. The  Iovance TIL platform  spans registrational trials and next-generation programs in additional solid tumors, including gene-edited and IL-12 tethered TIL therapies, next-generation IL-2, and precision immuno-oncology approaches. As the first and only company to take TIL therapy from concept to a broadly accessible commercial treatment, Iovance operates as an end-to-end cell therapy company, anchored by fully owned, centralized U.S.-based manufacturing that is scaled to serve thousands of cancer patients worldwide each year. For more information, please visit  www.iovance.com . Amtagvi® and its accompanying design marks, Proleukin ® , Iovance ® , and IovanceCares™ are trademarks and registered trademarks of Iovance Biotherapeutics, Inc. or its subsidiaries. All other trademarks and registered trademarks are the property of their respective owners. Information on Iovance’s broad, industry-leading patent portfolio is available on the Intellectual Property page on  www.iovance.com . Overview The Business Development Director, Sales is a senior field leader who sets the account strategy and drives commercial growth across a large U.S. territory in support of Iovance Biotherapeutics’ goals. Reporting to the Vice President, US Sales, this role leads the company’s relationships with the most important oncology accounts, authorized treatment centers, health systems, and health care leaders in the assigned territory. The Director decides where to focus effort for the greatest impact, works to remove barriers to patient access and operational readiness for cell therapy delivery, and brings customer and market insights back to senior leadership to help guide national decisions. Essential Functions and Responsibilities Strategic Account Leadership and Business Growth • Develop and own a multi-year business plan for the assigned territory that supports the national commercial strategy and sets clear priorities, goals, and resource needs. • Lead the strategy for the highest-value oncology accounts, academic medical centers, health systems, and authorized treatment centers, and decide where to focus time and effort for the greatest impact. • Build and maintain senior-level relationships with executives, department chairs, oncology and cell therapy program leaders, and other key decision makers. • Identify and pursue new business opportunities, including activating new treatment centers and expanding work with existing ones, to grow appropriate product utilization. • Monitor performance, account trends, referral patterns, and barriers to access across the territory, and make timely changes to plans. Report results, risks, and forecasts to the Vice President, US Sales. • Maintain accurate and timely documentation of account activity, opportunities, risks, and follow-up actions. Customer Education, Access, and Readiness • Educate senior customers on approved product information, treatment logistics, patient identification considerations, and the end-to-end cell therapy process in a compliant manner. • Partner with field reimbursement, market access, medical affairs, and patient services teams to resolve complex or escalated account-level access and operational barriers. • Guide account readiness by working with internal teams on onboarding, referral workflows, and treatment center operations so that centers are p